mometasone furoate nasal spray
ApprovedCompleted 0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Adenoids
Conditions
Adenoids
Trial Timeline
Aug 1, 2008 → Sep 1, 2009
NCT ID
NCT01098071About mometasone furoate nasal spray
mometasone furoate nasal spray is a approved stage product being developed by Organon for Adenoids. The current trial status is completed. This product is registered under clinical trial identifier NCT01098071. Target conditions include Adenoids.
What happened to similar drugs?
0 of 1 similar drugs in Adenoids were approved
Approved (0) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
20
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01098071 | Approved | Completed |
| NCT00491504 | Approved | Completed |
Competing Products
1 competing product in Adenoids
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Mometasone Furoate nasal spray + Placebo | Organon | Phase 3 | 34 |